pjasper's library 271 articles Export

	Mutational activation of ErbB family receptor tyrosine kinases: insights into mechanisms of signal transduction and tumorigenesis. [My Copy] Bioessays, Vol. 29, No. 6. (16 May 2007), pp. 558-565. by David J J. Riese, Richard M M. Gallo, Jeffrey Settleman posted to egfr mutant review by pjasper on 2007-05-22 20:38:16 as
	ErbB-3 mediates phosphoinositide 3-kinase activity in gefitinib-sensitive non-small cell lung cancer cell lines. [My Copy] Proc Natl Acad Sci U S A, Vol. 102, No. 10. (8 March 2005), pp. 3788-3793. by J. A. Engelman, P. A. Jänne, C. Mermel, et al.J. Pearlberg, T. Mukohara, C. Fleet, K. Cichowski, B. E. Johnson, L. C. Cantley posted to akt erbb3 inhibitor iressa nsclc by pjasper on 2007-05-22 18:40:08 as
	Allelic dilution obscures detection of a biologically significant resistance mutation in EGFR-amplified lung cancer. [My Copy] J Clin Invest, Vol. 116, No. 10. (October 2006), pp. 2695-2706. by J. A. Engelman, T. Mukohara, K. Zejnullahu, et al.E. Lifshits, A. M. Borrás, C. M. Gale, G. N. Naumov, B. Y. Yeap, E. Jarrell, J. Sun, S. Tracy, X. Zhao, J. V. Heymach, B. E. Johnson, L. C. Cantley, P. A. Jänne posted to egfr h3255 mutant resistance by pjasper on 2007-05-10 21:01:12 as along with 2 people guhjy klu
	Features of selective kinase inhibitors. [My Copy] Chem Biol, Vol. 12, No. 6. (June 2005), pp. 621-637. by Z. A. Knight, K. M. Shokat posted to inhibitor review by pjasper on 2007-05-10 20:55:43 as along with 4 people pslee Yanno anwazo seancutler
	Acquired resistance of lung adenocarcinomas to gefitinib or erlotinib is associated with a second mutation in the EGFR kinase domain. [My Copy] PLoS Med, Vol. 2, No. 3. (March 2005) by W. Pao, V. A. Miller, K. A. Politi, et al.G. J. Riely, R. Somwar, M. F. Zakowski, M. G. Kris, H. Varmus posted to egfr iressa mutant resistance t790m tarceva by pjasper on 2007-05-10 20:41:10 as
	Epidermal growth factor receptor (HER1) tyrosine kinase inhibitor ZD1839 (Iressa) inhibits HER2/neu (erbB2)-overexpressing breast cancer cells in vitro and in vivo. [My Copy] Cancer Res, Vol. 61, No. 24. (15 December 2001), pp. 8887-8895. by S. L. Moulder, F. M. Yakes, S. K. Muthuswamy, R. Bianco, J. F. Simpson, C. L. Arteaga posted to egfr erbb2 inactive_dimer iressa by pjasper on 2007-05-10 20:38:57 as
	ZD1839, a specific epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor, induces the formation of inactive EGFR/HER2 and EGFR/HER3 heterodimers and prevents heregulin signaling in HER2-overexpressing breast cancer cells. [My Copy] Clin Cancer Res, Vol. 9, No. 4. (April 2003), pp. 1274-1283. by J. Anido, P. Matar, J. Albanell, et al.M. Guzmán, F. Rojo, J. Arribas, S. Averbuch, J. Baselga posted to egfr erbb2 erbb3 inactive_dimer iressa by pjasper on 2007-05-10 20:36:31 as along with 1 person brianb
	Unliganded epidermal growth factor receptor dimerization induced by direct interaction of quinazolines with the ATP binding site. [My Copy] J Biol Chem, Vol. 272, No. 37. (12 September 1997), pp. 23247-23254. by C. L. Arteaga, T. T. Ramsey, L. K. Shawver, C. A. Guyer posted to egfr erbb2 inactive_dimer inhibitor by pjasper on 2007-05-10 20:34:56 as
	Signaling-inactive epidermal growth factor receptor/ligand complexes in intact carcinoma cells by quinazoline tyrosine kinase inhibitors. [My Copy] Cancer Res, Vol. 61, No. 15. (1 August 2001), pp. 5790-5795. by R. B. Lichtner, A. Menrad, A. Sommer, U. Klar, M. R. Schneider posted to egfr inhibitor by pjasper on 2007-05-10 20:30:15 as
	HER2 overexpression increases sensitivity to gefitinib, an epidermal growth factor receptor tyrosine kinase inhibitor, through inhibition of HER2/HER3 heterodimer formation in lung cancer cells. [My Copy] Cancer Res, Vol. 65, No. 10. (15 May 2005), pp. 4253-4260. by A. Hirata, F. Hosoi, M. Miyagawa, et al.S. Ueda, S. Naito, T. Fujii, M. Kuwano, M. Ono posted to egfr erbb2 inhibitor iressa nsclc by pjasper on 2007-05-10 19:52:18 as along with 1 person js229
	Insulin-like growth factor-I (IGF-I) induces epidermal growth factor receptor transactivation and cell proliferation through reactive oxygen species. [My Copy] Free Radic Biol Med, Vol. 42, No. 11. (1 June 2007), pp. 1651-1660. by D. Meng, X. Shi, B. H. Jiang, J. Fang posted to igf by pjasper on 2007-05-08 21:03:55 as along with 1 person guhjy
	The E3 ligase Aip4/Itch ubiquitinates and targets ErbB-4 for degradation. [My Copy] FASEB J (26 April 2007) by Jasminka Omerovic, Laura Santangelo, Eleonora Maria-Rosaria M. Puggioni, et al.Jordan Marrocco, Claudia Dall'armi, Camilla Palumbo, Francesca Belleudi, Lucia Di Marcotullio, Luigi Frati, Maria-Rosaria R. Torrisi, Gianni Cesareni, Alberto Gulino, Maurizio Alimandi posted to degradation erbb4 by pjasper on 2007-05-08 21:03:27 as
	MET Amplification Leads to Gefitinib Resistance in Lung Cancer by Activating ERBB3 Signaling [My Copy] Science, Vol. 316, No. 5827. (18 May 2007), pp. 1039-1043. by Jeffrey A. Engelman, Kreshnik Zejnullahu, Tetsuya Mitsudomi, et al.Youngchul Song, Courtney Hyland, Joon O. Park, Neal Lindeman, Christopher-Michael Gale, Xiaojun Zhao, James Christensen, Takayuki Kosaka, Alison J. Holmes, Andrew M. Rogers, Federico Cappuzzo, Tony Mok, Charles Lee, Bruce E. Johnson, Lewis C. Cantley, Pasi A. Janne posted to erbb3 met by pjasper on 2007-05-08 21:02:22 as along with 3 people and 1 group julius cwchen jackjackjjj SysbioMPI-TCells
	The oncogene HER2: its signaling and transforming functions and its role in human cancer pathogenesis [My Copy] Oncogene, Vol. aop, No. current. by M. M. Moasser posted to erbb2 review by pjasper on 2007-05-08 21:00:53 as along with 1 person guhjy
	Implication of the Insulin-like Growth Factor-IR Pathway in the Resistance of Non-small Cell Lung Cancer Cells to Treatment with Gefitinib. [My Copy] Clin Cancer Res, Vol. 13, No. 9. (1 May 2007), pp. 2795-2803. by Floriana Morgillo, Woo-Young Y. Kim, Edward S S. Kim, Fortunato Ciardiello, Waun Ki K. Hong, Ho-Young Y. Lee posted to igf by pjasper on 2007-05-08 21:00:26 as
	Alteration of the serum levels of the epidermal growth factor receptor and its ligands in patients with non-small cell lung cancer and head and neck carcinoma [My Copy] British Journal of Cancer, Vol. aop, No. current. (24 April 2007) by Y. Lemos-Gonzalez, F. J. Rodriguez-Berrocal, O. J. Cordero, C. Gomez, Paez posted to egf ligand nsclc by pjasper on 2007-05-08 20:59:01 as
	Erlotinib, an Effective Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, Induces p27KIP1 Upregulation and Nuclear Translocation in Association with Cell Growth Inhibition and Cell Cycle Arrest in Human Non-Small Cell Lung Cancer Cell Lines. [My Copy] Mol Pharmacol (24 April 2007) by Yi-He H. Ling, Tianhong Li, Ziqiang Yuan, Missak Haigentz Jr, Thomas K K. Weber, Roman Perez-Soler posted to inhibito nsclc p27 tarceva by pjasper on 2007-05-08 20:57:30 as
	Cross Talk between c-Met and Epidermal Growth Factor Receptor during Retinal Pigment Epithelial Wound Healing. [My Copy] Invest Ophthalmol Vis Sci, Vol. 48, No. 5. (May 2007), pp. 2242-2248. by K. P. Xu, F. S. Yu posted to egfr met by pjasper on 2007-05-08 20:55:53 as
	Oncogenic K-Ras signals through epidermal growth factor receptor and wild-type H-Ras to promote radiation survival in pancreatic and colorectal carcinoma cells. [My Copy] Neoplasia, Vol. 9, No. 4. (April 2007), pp. 341-348. by K. A. Cengel, K. R. Voong, S. Chandrasekaran, et al.L. Maggiorella, T. B. Brunner, E. Stanbridge, G. D. Kao, W. G. McKenna, E. J. Bernhard posted to igf by pjasper on 2007-05-08 20:55:26 as
	T cells are crucial for the anti-metastatic effect of anti-epidermal growth factor receptor antibodies [My Copy] Cancer Immunology, Immunotherapy by Greta Garrido, Pablo Lorenzano, Belinda Sánchez, et al.Irene Beausoleil, Daniel Alonso, Rolando Pérez, Luis Fernández posted to c225 cell egfr inhibitor t by pjasper on 2007-05-08 20:52:25 as
	Gefitinib-sensitive EGFR lacking residues 746-750 exhibits hypophosphorylation at tyrosine residue 1045, hypoubiquitination, and impaired endocytosis. [My Copy] DNA Cell Biol, Vol. 26, No. 3. (March 2007), pp. 178-185. by M. Furukawa, I. Nagatomo, T. Kumagai, et al.T. Yamadori, R. Takahashi, M. Yoshimura, T. Yoneda, Y. Takeda, S. Goya, H. Matsuoka, T. Kijima, M. Yoshida, T. Osaki, I. Tachibana, M. I. Greene, I. Kawase posted to activation egfr internalization mutant by pjasper on 2007-05-08 20:51:55 as
	Growth stimulation of non-small cell lung cancer cell lines by antibody against epidermal growth factor receptor promoting formation of ErbB2/ErbB3 heterodimers. [My Copy] Mol Cancer Res, Vol. 5, No. 4. (April 2007), pp. 393-401. by M. Maegawa, K. Takeuchi, E. Funakoshi, et al.K. Kawasaki, K. Nishio, N. Shimizu, F. Ito posted to c225 egfr erbb2 erbb3 inhibitor nsclc by pjasper on 2007-05-08 20:50:27 as
	Abi-1 forms an epidermal growth factor-inducible complex with Cbl: Role in receptor endocytosis. [My Copy] Cell Signal (22 February 2007) by Barbara E E. Tanos, Ann Marie M. Pendergast posted to abi-1 cbl egfr internalization by pjasper on 2007-05-08 20:46:50 as
	The discovery of highly selective erbB2 (Her2) inhibitors for the treatment of cancer. [My Copy] Bioorg Med Chem Lett (19 March 2007) by Blaise Lippa, Goss S S. Kauffman, Joel Arcari, et al.Tricia Kwan, Jinshan Chen, William Hungerford, Samit Bhattacharya, Xumiao Zhao, Courtney Williams, Jun Xiao, Leslie Pustilnik, Chunyan Su, James D D. Moyer, Ling Ma, Mary Campbell, Stefanus Steyn posted to erbb2 inhibitor by pjasper on 2007-05-08 20:46:17 as
	Second-Generation Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer [My Copy] Oncologist, Vol. 12, No. 3. (1 March 2007), pp. 325-330. by Lecia V. Sequist posted to 2ndgeneration egfr inhibitor nsclc review by pjasper on 2007-05-08 20:37:49 as along with 1 person kokphinchooi
	Unligated Epidermal Growth Factor Receptor Forms Higher Order Oligomers within Microclusters on A431 Cells That Are Sensitive to Tyrosine Kinase Inhibitor Binding. [My Copy] Biochemistry, Vol. 46, No. 15. (17 April 2007), pp. 4589-4597. by A. H. Clayton, M. L. Tavarnesi, T. G. Johns posted to a431 egfr oligomer structure by pjasper on 2007-05-08 19:12:05 as
	The Cbl-interacting protein TULA inhibits dynamin-dependent endocytosis. [My Copy] Exp Cell Res, Vol. 313, No. 8. (1 May 2007), pp. 1696-1709. by V. Bertelsen, K. Breen, K. Sandvig, E. Stang, I. H. Madshus posted to cbl egfr internalization tula by pjasper on 2007-05-08 19:11:19 as
	Structure-based mutagenesis of the substrate-recognition domain of Nrdp1/FLRF identifies the binding site for the receptor tyrosine kinase ErbB3. [My Copy] Protein Sci, Vol. 16, No. 4. (April 2007), pp. 654-661. by S. Bouyain, D. J. Leahy posted to erbb3 structure by pjasper on 2007-05-08 19:10:40 as along with 1 person and 1 group cursonivel1 cursonivel1
	Nuclear EGFR signalling network in cancers: linking EGFR pathway to cell cycle progression, nitric oxide pathway and patient survival. [My Copy] Br J Cancer, Vol. 96 Suppl (2007) by H. W. Lo, M. C. Hung posted to egfr nucleus by pjasper on 2007-05-08 19:08:25 as
	Targeting receptor tyrosine kinase signalling in small cell lung cancer (SCLC): What have we learned so far? [My Copy] Cancer Treat Rev (15 March 2007) by Barbara Fischer, Marin Marinov, Alexandre Arcaro posted to inhibitor review sclc by pjasper on 2007-05-08 19:05:26 as
	Activation of the EGFR gene target EphA2 inhibits epidermal growth factor-induced cancer cell motility. [My Copy] Mol Cancer Res, Vol. 5, No. 3. (March 2007), pp. 283-293. by A. B. Larsen, M. W. Pedersen, M. T. Stockhausen, M. V. Grandal, B. van Deurs, H. S. Poulsen posted to egfr epha2 by pjasper on 2007-05-08 19:04:25 as
	Protein-tyrosine phosphatase 1B is required for HER2/Neu-induced breast cancer. [My Copy] Cancer Res, Vol. 67, No. 6. (15 March 2007), pp. 2420-2424. by M. Bentires-Alj, B. G. Neel posted to breast erbb2 phosphatase by pjasper on 2007-05-08 19:03:15 as along with 1 person klu
	The EGF receptor Hokey-Cokey. [My Copy] Cancer Cell, Vol. 11, No. 3. (March 2007), pp. 209-211. by D. Niculescu-Duvaz, S. Whittaker, C. Springer, R. Marais posted to egfr review structure by pjasper on 2007-05-08 19:02:23 as
	Structures of lung cancer-derived EGFR mutants and inhibitor complexes: mechanism of activation and insights into differential inhibitor sensitivity. [My Copy] Cancer Cell, Vol. 11, No. 3. (March 2007), pp. 217-227. by C. H. Yun, T. J. Boggon, Y. Li, et al.M. S. Woo, H. Greulich, M. Meyerson, M. J. Eck posted to egfr inhibitor mutation review structure by pjasper on 2007-05-08 19:00:37 as along with 1 person and 1 group cursonivel1 cursonivel1
	Gastrin-releasing peptide activates Akt through the epidermal growth factor receptor pathway and abrogates the effect of gefitinib. [My Copy] Exp Cell Res, Vol. 313, No. 7. (15 April 2007), pp. 1361-1372. by X. Liu, D. L. Carlisle, M. C. Swick, A. Gaither-Davis, J. R. Grandis, J. M. Siegfried posted to egfr gastrin iressa resistance by pjasper on 2007-05-08 18:59:54 as
	EGFR kinase domain mutations – functional impact and relevance for lung cancer therapy [My Copy] Oncogene, Vol. aop, No. current. by D. Irmer, J. O. Funk, A. Blaukat, posted to egfr mutation review by pjasper on 2007-05-08 18:59:01 as
	A phase I clinical trial with monoclonal antibody ch806 targeting transitional state and mutant epidermal growth factor receptors. [My Copy] Proc Natl Acad Sci U S A, Vol. 104, No. 10. (6 March 2007), pp. 4071-4076. by A. M. Scott, F. T. Lee, N. Tebbutt, et al.R. Herbertson, S. S. Gill, Z. Liu, E. Skrinos, C. Murone, T. H. Saunder, B. Chappell, A. T. Papenfuss, A. M. Poon, W. Hopkins, F. E. Smyth, D. MacGregor, L. M. Cher, A. A. Jungbluth, M. W. Brechbiel, R. Murphy, A. W. Burgess, E. W. Hoffman, T. G. Johns, L. J. Old posted to ch806 egfr inhibitor by pjasper on 2007-05-08 18:57:28 as
	The EGFR inhibitor gefitinib suppresses ligand-stimulated endocytosis of EGFR via the early/late endocytic pathway in non-small cell lung cancer cell lines. [My Copy] Histochem Cell Biol, Vol. 127, No. 5. (May 2007), pp. 541-553. by Y. Nishimura, B. Bereczky, M. Ono posted to egfr internalization iressa by pjasper on 2007-05-08 18:56:46 as
	Antibody-dependent cellular cytotoxicity mediated by cetuximab against lung cancer cell lines. [My Copy] Clin Cancer Res, Vol. 13, No. 5. (1 March 2007), pp. 1552-1561. by J. Kurai, H. Chikumi, K. Hashimoto, et al.K. Yamaguchi, A. Yamasaki, T. Sako, H. Touge, H. Makino, M. Takata, M. Miyata, M. Nakamoto, N. Burioka, E. Shimizu posted to c225 egfr inhibitor by pjasper on 2007-05-08 18:55:26 as
	Differential constitutive activation of the epidermal growth factor receptor in non-small cell lung cancer cells bearing EGFR gene mutation and amplification. [My Copy] Cancer Res, Vol. 67, No. 5. (1 March 2007), pp. 2046-2053. by T. Okabe, I. Okamoto, K. Tamura, et al.M. Terashima, T. Yoshida, T. Satoh, M. Takada, M. Fukuoka, K. Nakagawa posted to activation egfr mutation nsclc by pjasper on 2007-05-08 18:54:50 as
	Lung cancer cell lines harboring MET gene amplification are dependent on Met for growth and survival. [My Copy] Cancer Res, Vol. 67, No. 5. (1 March 2007), pp. 2081-2088. by B. Lutterbach, Q. Zeng, L. J. Davis, et al.H. Hatch, G. Hang, N. E. Kohl, J. B. Gibbs, B. S. Pan posted to egfr met by pjasper on 2007-05-08 18:53:41 as
	Epidermal growth factor receptor mutants from human lung cancers exhibit enhanced catalytic activity and increased sensitivity to gefitinib. [My Copy] Cancer Res, Vol. 67, No. 5. (1 March 2007), pp. 2325-2330. by R. Mulloy, A. Ferrand, Y. Kim, et al.R. Sordella, D. W. Bell, D. A. Haber, K. S. Anderson, J. Settleman posted to egfr iressa mutation nsclc by pjasper on 2007-05-08 18:52:47 as
	Epidermal growth factor (EGF) receptor endocytosis is accompanied by reorganization of microtubule system in HeLa cells. [My Copy] Cell Biol Int, Vol. 31, No. 4. (April 2007), pp. 349-359. by M. V. Kharchenko, A. A. Aksyonov, M. M. Melikova, E. S. Kornilova posted to egfr internalization by pjasper on 2007-05-08 18:51:12 as
	HER2 therapy. Small molecule HER-2 tyrosine kinase inhibitors [My Copy] Breast Cancer Research, Vol. 9 (02 March 2007), 205. by Neil Spector, Wenle Xia, Iman El-Hariry, Yossi Yarden, Sarah Bacus posted to erbb2 inhibitor by pjasper on 2007-05-08 18:50:28 as along with 1 person klu
	Consequences of Direct Versus Indirect Activation of Epidermal Growth Factor Receptor in Intestinal Epithelial Cells Are Dictated by Protein-tyrosine Phosphatase 1B. [My Copy] J Biol Chem, Vol. 282, No. 18. (4 May 2007), pp. 13303-13315. by D. F. McCole, A. Truong, M. Bunz, K. E. Barrett posted to activation egfr phosphatase by pjasper on 2007-05-08 18:48:47 as along with 1 person guhjy
	Dual EGFR and mTOR targeting in squamous cell carcinoma models, and development of early markers of efficacy [My Copy] British Journal of Cancer, Vol. aop, No. current. (06 March 2007) by A. Jimeno, P. Kulesza, J. Wheelhouse, et al.A. Chan, X. Zhang, E. Kincaid, R. Chen, D. P. Clark, A. Forastiere, M. Hidalgo posted to egfr inhibitor mtor by pjasper on 2007-05-08 18:48:03 as
	Combination of EGFR gene copy number and protein expression predicts outcome for advanced non-small-cell lung cancer patients treated with gefitinib. [My Copy] Ann Oncol, Vol. 18, No. 4. (April 2007), pp. 752-760. by F. Hirsch, M. Varella-Garcia, F. Cappuzzo, et al.J. McCoy, L. Bemis, A. Xavier, R. Dziadziuszko, P. Gumerlock, K. Chansky, H. West, A. Gazdar, L. Crino, D. Gandara, W. Franklin, P. Bunn posted to amplification egfr inhibitor iressa nsclc by pjasper on 2007-05-08 18:46:53 as
	Epidermal growth factor receptor mutations in lung cancer [My Copy] Nature Reviews Cancer, Vol. 7, No. 3., pp. 169-181. by Sreenath V. Sharma, Daphne W. Bell, Jeffrey Settleman, Daniel A. Haber posted to egfr mutation nsclc review by pjasper on 2007-05-08 18:44:57 as along with 1 person kochhan
	Spatial regulation of EGFR signaling by Sprouty2. [My Copy] Curr Biol, Vol. 17, No. 5. (6 March 2007), pp. 455-461. by H. J. Kim, L. J. Taylor, D. Bar-Sagi posted to egfr sprouty by pjasper on 2007-05-08 18:43:53 as
	Dual silencing of the EGF and type 1 IGF receptors suggests dominance of IGF signaling in human breast cancer cells. [My Copy] Biochem Biophys Res Commun, Vol. 355, No. 3. (13 April 2007), pp. 700-706. by J. Riedemann, M. Sohail, V. M. Macaulay posted to breast egfr igf by pjasper on 2007-05-08 18:43:28 as

Note: You may cite this page as: http://www.citeulike.org/user/pjasper

Result page: 1 2 3 4 5 6 Next

egfr	74
inhibitor	67
iressa	44
erbb2	43
nsclc	43
review	43
mutation	40
breast	28
internalization	25
activation	24
igf	23
erbb3	18
structure	16
akt	12
resistance	11
mutant	10
c225	10
signaling	9
erbb4	8
herceptin	8
ligand	7
src	7
tarceva	7
phosphatase	6
dimerization	6
novel	6
apoptosis	5
v3	5
cbl	5
stat3	5
erbb	5
amplification	5
degradation	4
p38	4
migration	4
transformation	4
adam	3
genomics	3
deletion	3
met	3
inactive_dimer	3
pten	3
hsp90	2
pkc	2
ubiquitin	2
crosstalk	2
prostate	2
endosome	2
hsp70	2
egf	2
nucleus	2
interaction	2
hrg	2
erk	2
mtor	2
t790m	2
inhibitors	2
hki-272	2
ligands	2
gab1	2
a431	2
shp2	2
transcription	2
lapatinib	2
trafficking	2
h3255	1
t47d	1
biochemistry	1
antibody	1
immunity	1
binding	1
epigen	1
oligomer	1
receptor	1
gastrin	1
azd3409	1
2ndgeneration	1
grb2	1
celecoxib	1
bcr	1
regulation	1
uim	1
molecule	1
y845	1
tace	1
sprouty	1
ch806	1
p27	1
raft	1
icr62	1
ekb569	1
tnf	1
c-jun	1
l858r	1
comment	1
iress	1
amphiregulin	1
processing	1
colon	1
cell	1
egf-independent	1
epha2	1
mcf7	1
p53	1
peptabody	1
single	1
calmodulin	1
tnfa	1
cancer	1
inhibito	1
glioma	1
n-wasp	1
geldanamycin	1
plcg1	1
color	1
mapk	1
hdac	1
panitumumab	1
abl	1
ci-1033	1
mouse	1
tgfa	1
affinity	1
atp	1
intersectin	1
autocrine	1
hbegf	1
proliferation	1
trastuzumab	1
prolactin	1
pertuzumab	1
survivin	1
er	1
lipid	1
ovarian	1
simulation	1
modeling	1
eps15	1
endocytosis	1
genomic	1
heregulin	1
bms-599626	1
glioblastoma	1
biomarker	1
sclc	1
massspec	1
ag1478	1
technical	1
erpa	1
abi-1	1
t	1
motility	1
interanalization	1
inhibition	1
cool1	1
2c4	1
cklfsf8	1
tula	1
pancreas	1
bnip3l	1
rnai	1
shc	1
bad	1
tetramer	1
e-cadhering	1

pjasper's library 271 articles Export

pjasper's tags